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Evaluation of Patients With
Possible Cardiac Chest Pain
A Way Out of the Jungle*
Erik P. Hess, MD, MSC,†‡ Allan S. Jaffe, MD§
Rochester, Minnesota
Emergency department (ED) overcrowding is a national
health problem. From 1997 to 2007, the annual number of
ED visits in the United States increased from 95 to 117
million, whereas the number of EDs decreased by 10% (1).
This increased volume has put demands for acute care
services at more than can be provided: 50% of urban
hospitals and 31% of rural hospitals continuously operate at
or over capacity (2). ED overcrowding is associated with
adverse cardiovascular outcomes (3), reduced use of
guideline-recommended therapies, and a higher risk of
recurrent myocardial infarction (4).
See page 2091
Given that chest pain is the second most common
reason patients present to EDs across the United States
(1), rapidly identifying patients with acute coronary
syndrome (ACS) and efficiently identifying low-risk pa-
tients who can be safely evaluated in the outpatient
setting is a critical issue. A key to facilitating the care of
these patients is early risk stratification, proper use of
sensitive and specific markers (e.g., cardiac troponin
[cTn]), and comprehensive follow-up. This effort for
low-risk patients is what has been evaluated by Than et
al. in this issue of the Journal (5).
A total of 1,975 consenting adults presenting with symp-
toms suggestive of ACS were prospectively enrolled from 2
urban EDs. The investigators identified a low-risk group
using an accelerated diagnostic protocol (ADP) that in-
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honoraria from theheart.org.cluded patients with a Thrombolysis In Myocardial Infarc-
tion (TIMI) risk score of 0 at presentation, no new ischemic
changes on the initial electrocardiogram (ECG), and car-
diac troponin I (cTnI) concentrations at 0 and 2 h after
arrival below the institutional cutoff for cTn elevation. The
investigators were confident that close short-term follow-up
with primary care physicians would occur in their local
setting. Patients were prospectively followed to ascertain the
occurrence of major adverse cardiac events (MACE), including
ruling in for acute myocardial infarction (AMI) on the 12-h
blood sample. The remainder of events included a composite of
cardiac death, cardiac arrest, emergency revascularization, car-
diogenic shock, ventricular arrhythmia requiring intervention,
high-degree atrioventricular block requiring intervention, and
AMI within 30 days of ED presentation.
Overall, of the 1,975 patients, there were 302 (15%)
patients who had a MACE within 30 days. However, only
1 of these occurred in the 392 patients (20% of the cohort)
who were ADP negative, giving the ADP a sensitivity of
99.7% and specificity of 23.4%. If this protocol were
implemented in clinical practice, it could potentially identify
20% of ED patients who could be safely discharged within
2 to 3 h of presentation.
However, there are very significant limitations to this inves-
tigation. Specifically, 18% of ADP negative patients under-
went therapeutic and 2% underwent procedural interventions
during their initial presentation or within 30 days of the ED
visit, introducing the risk of outcome misclassification due to
cointervention. Moreover, 74% of these patients had additional
investigations, 81% of which were cardiac stress tests, suggest-
ing that further risk stratification after the ED visit was
deemed essential in the majority of ADP negative patients.
Thus, it could be argued that the results obtained reflect the
design of the study, with more prolonged observation of some
of the patients and aggressive follow-up in the others. Al-
though this approach would be helpful to EDs, it would be
ideal if the results did not depend so heavily on follow-up
evaluations. This may work well in the 2 centers involved, but
may not be the case in some others. Thus, there is room for
improvement in the proximate elements of the evaluation,
including the risk score and how cTn was used.
The TIMI risk score was originally developed to predict risk
in hospitalized high-risk ACS patients. A recent meta-analysis
of 17,265 patients from 10 prospective ED cohort studies (6)
observed statistical heterogeneity among studies related to
differences in the prevalence of cardiac events between cohorts.
This would lead to anticipation of variability in the perfor-
mance of the ADP among practice settings based on the
baseline prevalence of MACE in a given population.
Several prediction models have been developed that
may be better tailored for use in the ED setting. The
North American Chest Pain Rule incorporates the clini-
cian’s assessment of chest pain etiology as well as readily
available data from the initial ECG, cTn, and cardiovas-
cular history. It had a sensitivity of 100% and a specificity
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(7). The HEART (History, ECG, Age, Risk Factors,
and Troponin) score has also been developed (8) in ED
chest pain patients as well as the Vancouver chest pain
rule (9). This growing literature suggests that additional
investigations will provide the needed refinements to
identify low-risk ACS patients.
In addition, although the cTn assays used were rea-
sonable fourth-generation cTnI assays, they were used at
a higher cutoff value than suggested by the guidelines
(10). Thus, by definition, they might have missed more
patients than would be ideal. With more sensitive assays,
such an approach may be improved, but it is unclear,
especially in patients who present very early, that 2 h will
provide a robust ability to exclude all AMIs. However, there
re approaches that may help. Recently, Body et al. (11)
reported that patients with an initial highly sensitive
cTnI value below the level of detection had negligible
rates of MACE over a 30-day period. If a group that had
chest pain 6 h before presentation without intercurrent
symptoms were added, this group might be as high as
40% of the ED cohort. If so, it might be that many
patients could have AMI excluded at the time of admis-
sion. This would still leave some patients with possible
unstable angina, but as assay sensitivity improves, this
group would be smaller and smaller. The tension, how-
ever, is clear. There will be a much larger number of cTn
elevations with these assays, both due to chronic diseases
and acute diseases such as sepsis, stroke, and pulmonary
embolism (12).
Where do we go from here? Is there a safe and efficient
way out of the jungle? For the short term, an effective
solution to the dilemma of ED overcrowding is, of neces-
sity, collaborative. Although we anticipate improvements in
our ability to define a low-risk cohort and in metrics
necessary to optimally use high sensitivity cTn assays, a
multidisciplinary team approach with good follow-up is
needed to provide consistent, high-quality health care for
possible ACS patients in the context of an emergency care
system at its breaking point.Reprint requests and correspondence: Dr. Erik P. Hess, De-
partment of Emergency Medicine, Mayo Clinic College of
Medicine, 200 First Street SW, Rochester, Minnesota 55905.
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